Source link : https://www.newshealth.biz/health-news/novel-ptsd-treatment-improved-symptom-severity-in-phase-iib-trial/
An investigational therapy for post-traumatic stress disorder (PTSD) improved symptom severity as soon as one month into a 12-week, phase IIb study. In a modified intent-to-treat analysis of 182 patients, treatment effects with BNC210 — a novel α7 nicotinic acetylcholine receptor-negative allosteric modulator — were seen as early as week 4 versus placebo, with a […]
Author : News Health
Publish date : 2024-12-08 22:00:00
Copyright for syndicated content belongs to the linked Source.